You have 9 free searches left this month | for more free features.

Ranibizumab

Showing 51 - 75 of 714

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Diabetic Macular Edema: Relevance of Staging Progression on

Recruiting
  • Diabetic Macular Edema
  • intravitreal administration of bevacizumab/ranibizumab/aflibercept/desamethazone
  • Lugano, Switzerland
    ESASO Scientific Projects
Oct 4, 2021

Diabetic Retinopathy Trial in Puerto Rico, United States (PDS Implant Pre-Filled with 100 mg/mL Ranibizumab, Intravitreal

Active, not recruiting
  • Diabetic Retinopathy
  • PDS Implant Pre-Filled with 100 mg/mL Ranibizumab
  • Intravitreal Ranibizumab 0.5 mg Injection
  • Dothan, Alabama
  • +75 more
Aug 3, 2022

Central Retinal Vein Occlusion Trial in Stockholm (Aflibercept, Ranibizumab)

Completed
  • Central Retinal Vein Occlusion
  • Stockholm, Sweden
    St Eriks Eye Hospital
Dec 3, 2020

Neovascular Age-Related Macular Degeneration Trial in United States (PDS Implant filled with 100 mg/mL Ranibizumab, Intravitreal

Completed
  • Neovascular Age-Related Macular Degeneration
  • PDS Implant filled with 100 mg/mL Ranibizumab
  • Intravitreal Injections of 10 mg/mL Ranibizumab
  • Mesa, Arizona
  • +76 more
Feb 28, 2022

Wet Age-related Macular Degeneration Trial in Chengdu (MW02, Lucentis)

Recruiting
  • Wet Age-related Macular Degeneration
  • Chengdu, Si Chuan, China
    West China Hospital of Sichuan University
Mar 17, 2022

Diabetic Macular Edema Trial in Cleveland, Mayfield Heights (Ranibizumab)

Completed
  • Diabetic Macular Edema
  • Ranibizumab
  • Cleveland, Ohio
  • +1 more
Oct 30, 2020

Neovascular Age-Related Macular Degeneration (nAMD) Trial in United States (RGX-314 Dose 1, RGX-314 Dose 2, Ranibizumab

Recruiting
  • Neovascular Age-Related Macular Degeneration (nAMD)
  • RGX-314 Dose 1
  • +3 more
  • Phoenix, Arizona
  • +14 more
Mar 29, 2022

Age-related Macular Degeneration (AMD) Trial in Worldwide (ranibizumab)

Completed
  • Age-related Macular Degeneration (AMD)
  • ranibizumab
  • Vienna, Austria
  • +57 more
Sep 2, 2021

Diabetic Retinopathy, Macular Edema Trial in Cleveland (aflibercept)

Completed
  • Diabetic Retinopathy
  • Macular Edema
  • Cleveland, Ohio
    Cole Eye Institute, Cleveland Clinic
Jan 25, 2021

Exudative Age Related Macular Degeneration Trial in Charlotte, Statesville (Ranibizumab Injection [Lucentis])

Completed
  • Exudative Age Related Macular Degeneration
  • Ranibizumab Injection [Lucentis]
  • Charlotte, North Carolina
  • +1 more
Oct 19, 2020

Diabetic Macular Edema Trial in Beverly Hills, West Columbia, Houston (Ranibizumab 0.3 mg intravitreal injection, Guided Laser

Completed
  • Diabetic Macular Edema
  • Ranibizumab 0.3 mg intravitreal injection
  • Guided Laser Photocoagulation
  • Beverly Hills, California
  • +2 more
Oct 23, 2020

Diabetic Retinopathy, Retinal Neovascularisation Trial in London (Ranibizumab, Saline)

Completed
  • Diabetic Retinopathy
  • Retinal Neovascularisation
  • London, United Kingdom
    Moorfields Eye Hospital
Sep 7, 2020

Ocular Adverse Events in Neovascular Agerelated Macular

Completed
  • Age-related Macular Degeneration (AMD)
  • Aflibercept
  • +2 more
  • East Hanover, New Jersey
    Novartis Investigative Site
Dec 15, 2021

Neovascular Age-related Macular Degeneration (nAMD) Trial in Worldwide (Ranibizumab, Port Delivery System with Ranibizumab)

Recruiting
  • Neovascular Age-related Macular Degeneration (nAMD)
  • Ranibizumab
  • Port Delivery System with Ranibizumab
  • Capital Federal, Argentina
  • +84 more
Aug 2, 2022

Retinopathy of Prematurity Trial in Worldwide (Ranibizumab)

Active, not recruiting
  • Retinopathy of Prematurity
  • Ranibizumab
  • Sacramento, California
  • +72 more
May 23, 2022

Ophthalmopathy Trial in Asyut (Ranibizumab, triamcinolone acetate)

Unknown status
  • Ophthalmopathy
  • Ranibizumab
  • triamcinolone acetate
  • Asyut, Egypt
    Wael
Jul 2, 2020

Cytokeratin 8 Level in Age-related Macular Degeneration

Completed
  • Age-related Macular Degeneration
  • Ranibizumab
  • Goyang, Korea, Republic of
  • +1 more
Dec 5, 2020

Diabetic Retinopathy Trial in London (Ranibizumab, Modified ETDRS laser)

Completed
  • Diabetic Retinopathy
  • Ranibizumab
  • Modified ETDRS laser
  • London, United Kingdom
    Moorfields Eye Hospital
Sep 7, 2020

Age Related Macular Degeneration Trial in China (HLX04-O,recombinant anti-vascular endothelial growth factor (VEGF) humanized

Recruiting
  • Age Related Macular Degeneration
  • HLX04-Oļ¼Œrecombinant anti-vascular endothelial growth factor (VEGF) humanized monoclonal antibody ophthalmic injection
  • Lucentis
  • Bengbu, Anhui, China
  • +40 more
Apr 27, 2022

Intravitreal Ranibizumab in Recurrent ROP

Completed
  • Retinopathy of Prematurity
  • intravitreal injection of Ranibizumab
  • Mansoura, Dakahlia, Egypt
    Mansoura University
Aug 31, 2020

Branch Retinal Vein Occlusion Trial in BeiJing (601 1.25mg, Ranibizuman 0.5 mg)

Not yet recruiting
  • Branch Retinal Vein Occlusion
  • 601 1.25mg
  • Ranibizuman 0.5 mg
  • BeiJing, Beijing, China
    BeiJing Hospital
Dec 8, 2020

Neovascular Age Related Macular Degeneration Trial in Torrance (OCT, Multifocal ERG, Microperimetry, Ranibizumab Ophthalmic)

Completed
  • Neovascular Age Related Macular Degeneration
  • OCT, Multifocal ERG, Microperimetry
  • Ranibizumab Ophthalmic
  • Torrance, California
    Retina Macula Institute
Sep 1, 2020

Ocular Adverse Events in Neovascular Age-related Macular

Completed
  • Age-related Macular Degeneration (AMD)
  • Aflibercept
  • +2 more
  • East Hanover, New Jersey
    Novartis Investigative Site
Dec 15, 2021

OCTA and Polypoidal Choroidal Vasculopathy

Completed
  • Polypoidal Choroidal Vasculopathy
  • Ranibizumab Injection
  • Naples, Italy
    University of Naples "Federico II"
Jan 14, 2021

Age-Related Maculopathy, Choroidal Neovascularization Trial in Tulsa (Ranibizumab, Verteporfin)

Completed
  • Age-Related Maculopathy
  • Choroidal Neovascularization
  • Tulsa, Oklahoma
    Eagle Mountain Vision
Nov 4, 2020